|
|
|
| Analysis of medication rules of palpitation in Revisiting the Jinjian of Ancient and Modern Famous Doctors·Palpitation and Severe Palpitation Volume |
| LIU Jianzhao1 GAO Hongmei2 DONG Yujiang2 |
1.The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Shandong Province, Jinan 250000, China;
2.Department of Cardiovascular Medicine, the Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Shandong Province, Jinan 250000, China
|
|
|
|
Abstract Objective To analyze the medication rules of physicians in the past dynasties in the treatment of palpitation in Revisiting the Jinjian of Ancient and Modern Famous Doctors·Palpitation and Severe Palpitation Volume. Methods Common prescriptions used by physicians of all ages for palpitation and severe palpitation, which were included in the book Revisiting the Jinjian of Ancient and Modern Famous Doctors·Palpitation and Severe Palpitation Volume were reviewed and screened. The frequency, four nature and five flavours, channel tropism of drugs, and other properties were counted. The SPSS Modeler 18.0 was used for association rule analysis of high-frequency drugs, and the statistical software IBM SPSS Statistics 20.0 was used for factor analysis of high-frequency drugs. Results A total of 61 physicians, 312 ancient remedies and 320 traditional Chinese medicines were involved in this study, with a total frequency of 2 995 times. According to statistics, there were 36 kinds of high frequency drugs. The flavour of drugs was mainly sweet; the drug property was mainly flat; the main channel was the heart channel. The core of the drug category was tonifying deficiency drugs. The analysis of high-frequency drug association rules showed 21 common combinations. Factor analysis yielded 11 groups of common factors. Conclusion The treatment of palpitation in Revisiting the Jinjian of Ancient and Modern Famous Doctors·Palpitation and Severe Palpitation Volume mainly focuses on nourishing yin and nourishing blood, often combined with invigorating xinyang, nourishing the heart and calming the spirit, heat-clearing, resolving fluid retention, and dispelling phlegm, and other drugs.
|
|
|
|
|
|
[1] 王占武，耿晓娟.心悸中医证治现代研究进展[J].天津中医药大学学报，2021，40（4）：539-544.
[2] 李剑颖，吴大真.心悸的临床诊断与辨证施治[J].中医临床研究，2011，3（8）：95，97.
[3] 宁娜，胡晓敏，光红梅.抗心律失常药物的非临床心血管系统安全性评价研究进展[J].药物评价研究，2019，42（9）：1881-1885.
[4] 单书健.重订古今名医临证金鉴·心悸怔忡卷[M].北京：中国医药科技出版社，2017.
[5] 国家药典委员会.中华人民共和国药典[M].一部.北京：中国医药科技出版社，2020.
[6] 国家中医药管理局，《中华本草》编委会主编.中华本草[M].上海：上海科学技术出版社，1999.
[7] 钟赣生.中药学[M].北京：中国中医药出版社，2016.
[8] 刘保松，白明，苗明三.基于关联规则和因子分析研究糖尿病肾病中药组方用药规律[J].中国现代应用药学，2019， 36（7）：781-785.
[9] 陈洁，宋文燕，姜涛.心悸病病名及症状历史沿革[J].山西中医，2017，33（6）：59-62.
[10] 耿晓娟，阮士怡，张军平.心悸病因病机及方药演变初探[J].中医杂志，2018，59（20）：1717-1721.
[11] 贾所学.药品化义[M].北京：中国中医药出版社，2015.
[12] 张延书.生地临床配伍运用简要[J].湖北中医杂志，1990（2）：37.
[13] 张星.当归配伍应用[J].河南中医，2021，41（11）：1643- 1646.
[14] 张静，崔兴，陈维达，等.当归多糖干预调节再生障碍性贫血小鼠骨髓单个核细胞线粒体自噬稳态的实验研究[J].现代中西医结合杂志，2019，28（18）：1939-1942， 1946.
[15] 张红梅，李红辉，唐石欢，等.当归多糖调控SIRT1/ FOXO1通路抑制小鼠造血干细胞衰老[J].江西医药，2021， 56（8）：1108-1111.
[16] 王瑞琼.当归挥发油对垂体后叶素致大鼠心肌缺血的保护作用及对氯化钙诱导的实验性大鼠心律失常的影响[C]//海峡两岸暨CSNR全国第十届中药及天然药物资源学术研讨会论文集，2012：597-598.
[17] 王多德，席孝萍，刘吉宗，等.当归四逆汤治疗阴寒凝滞型冠心病不稳定性心绞痛疗效观察[J].西部中医药，2021，34（5）：120-121.
[18] 田代华.黄帝内经·素问[M].北京：人民卫生出版社，2016.
[19] 胡小鹰，彭国平，陈汝炎.甘草总黄酮抗心律失常作用研究[J].中草药，1996（12）：733-735.
[20] 邢作英，王永霞，朱明军，等.桂枝甘草汤及其拆方含药血清对豚鼠心室肌细胞L-型钙通道的影响[J].中国中西医结合杂志，2018，38（3）：331-335.
[21] 王肯堂.证治准绳[M].北京：人民卫生出版社，2014.
[22] 李晓萌，黄健.桂枝甘草龙骨牡蛎加味汤治疗冠心病室性早搏的疗效分析[J].当代医学，2021，27（31）：144- 145.
[23] 张懿，张良洁，卞雷斯，等.柴胡加龙骨牡蛎汤治疗心悸病的研究进展[J].中国医药，2022，17（1）：136-139.
[24] 史金玉，孙怿泽，唐卓然，等.柴胡加龙骨牡蛎汤治疗冠心病合并焦虑抑郁的Meta分析[J].世界中医药，2021， 16（16）：2427-2434.
[25] 刘华东，朱益敏，范欣生，等.《太平惠民和剂局方》二陈汤方证本义探析[J].现代中医药，2013，33（5）：37- 39.
[26] 张立平，郑齐.经典名方中生甘草与炙甘草应用分析[J].中国中医基础医学杂志，2022，28（9）：1495-1498.
[27] 宋雪，刘思佳，樊建，等.基于炙甘草与生甘草化学成分、药理作用差异的临床应用探讨[J].中国医药科学，2022，12（19）：114-117，159.
[28] 李晓东，杨培民，齐立红.酸枣仁炮制前后有效成分的比较分析[J].山东中医杂志，1999（5）：33-34.
[29] 高红宁，殷奕，严国俊.UPLC-UV-ELSD测定不同产地炒酸枣仁饮片中酸枣仁皂苷A、酸枣仁皂苷B、斯皮诺素和6′′′-阿魏酰斯皮诺素的含量[J].中国当代医药，2021，28（6）：8-12. |
|
|
|
